Multiple Sclerosis and Related Disorders

Papers
(The H4-Index of Multiple Sclerosis and Related Disorders is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Sarcopenia in patients with multiple sclerosis83
Opsoclonus myoclonus syndrome in a postpartum period79
Feasibility and usability evaluation of a gamified fatigue management mobile application for persons with multiple sclerosis in everyday life69
Self-reported cognitive function mediates the relationship between employment status and cognitive functioning in persons with multiple sclerosis67
Smoking, cardiovascular risk factors and LRP2 gene variation: Associations with disease severity, cognitive function and brain structure in primary progressive multiple sclerosis62
Siponimod following Alemtuzumab in secondary progressive MS: investigating sequential therapy–A case series59
Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression50
The Use of Ocrelizumab in Pediatric Multiple Sclerosis Patients in the United Arab Emirates: A Retrospective Study50
Involvement Peripheral Nerve System in Multiple Sclerosis49
Leber Hereditary Optic Neuropathy Presenting as Bilateral Visual Loss and White Matter Disease48
Sexual Dysfunctions and Self-Esteem in Multiple Sclerosis: A Tunisian Study48
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets47
Plasma 24-hydroxycholesterol is associated with narrower common carotid artery and greater flow velocities in relapsing multiple sclerosis47
The Relationship Between Smoking and Multiple Sclerosis Severity in Saudi Arabia47
A one year follow of patients with multiple sclerosis during COVID-19 pandemic: A cross-sectional study in Qom province, Iran47
Missed MS or MIMS not prodromal MS: Expanding the diagnostic MS spectrum42
Evaluation of adherence to treatment in patients with multiple sclerosis from Latin America41
Clinical and imaging features of patients with late-onset myelin oligodendrocyte glycoprotein antibody-associated disease40
Transcutaneous spinal cord stimulation improves postural stability in individuals with multiple sclerosis39
Characteristics of recurrence risk perception and coping strategies in patients with neuromyelitis optica spectrum disorder: A qualitative study39
Middle-age people with multiple sclerosis demonstrate similar mobility characteristics to neurotypical older adults39
Multimodal peripheral fluid biomarker analysis in clinically isolated syndrome and early multiple sclerosis39
Identification of common susceptibility genes and drug target genes in multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis and its value to guide clinical treatment38
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy38
Italian translation and psychometric validation of the ABILHAND-26 and its correlation with upper limb objective and subjective measures in multiple sclerosis subjects38
Peripheral nerve vulnerability as risk factor for multiple sclerosis: Possible insights from Neurofibromatosis type 2 (NF2)37
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: A population-based study on Tuscan residents37
Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, Iran37
Managing multiple sclerosis in the Covid19 era: a review of the literature and consensus report from a panel of experts in Saudi Arabia36
Lipid measures are associated with cognitive functioning in multiple sclerosis patients36
Effects of constraint induced movement therapy in patients with multiple sclerosis: A systematic review36
Diagnosing ‘transition’ to secondary progressive multiple sclerosis (SPMS): A step-by-step approach for clinicians35
Macular vascular density alteration patterns in paediatric optic neuritis patients with serum MOG antibody positivity detected by optic coherence tomography angiography35
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis35
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination34
0.087461948394775